Wednesday, August 20, 2014

SAVE a Life .Make someone SMILE forever..


         ||SAVE A LIFE||
A 09 yrs boy BIBHU KRUPA PRUSTY from Bahragora, Jharkhand  is suffering from AML (Acute Myeloid Leukemia) .Belongs to a poor family ,his father Jayant Pusty is a driver n own a small shop and earn his daily living hood . His first treatment of Chemo costed 3.5 Lakhs. And the further treatment of chemotherapy n bone marrow transplantation will cost around 10 Lakhs.TATA MEMORIAL CENTRE, Salt Lake, Kolkata, West Bengal is the best doctors and treatment is dupposed to be carried out there.
   The Bone marrow will be given by sister to his patient brother. After this transplantation n Chemo he will return to his normal life and will again smile , laugh, play, shout and their family will live happily. PLEASE Help Mr Jayant Prusty .

Contact no.-08596056127,08002473898
SBI Account . Jayant Prusty (Bharagora Branch) Account no- 30431994555






A small Intoduction -(http://en.wikipedia.org/wiki/Acute_myeloid_leukemia)
Acute myeloid leukemia (AML), also known as acute myelogenous leukemia or acute nonlymphocytic leukemia (ANLL), is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age.

First-line treatment of AML consists primarily of chemotherapy, and is divided into two phases: induction and postremission (or consolidation) therapy. The goal of induction therapy is to achieve a complete remission by reducing the number of leukemic cells to an undetectable level; the goal of consolidation therapy is to eliminate any residual undetectable disease and achieve a cure.Hematopoietic stem cell transplantation is usually considered if induction chemotherapy fails or after a patient relapses, although transplantation is also sometimes used as front-line therapy for patients with high-risk disease.

No comments:

Post a Comment